Cutaneous Manifestations Among Hospitalised COVID-19 Infected Children from Northern India: A Cross-sectional Study

Abstract

Introduction: Novel Coronavirus Disease-2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Besides the systemic manifestations, mucocutaneous involvement has also been reported with COVID-19. Reports suggest that the mucocutaneous manifestations may differ in children and adult patients. Aim: To describe the prevalence and characteristics of cutaneous manifestations among COVID-19 infected Children. Materials and Methods: This descriptive cross-sectional study was undertaken in Shaheed Hasan Khan Mewati, Government Medical College and Hospital, Nuh, Haryana, India. Fifty SARSCoV-2 positive children, admitted during the study period (between July, 2020 to December, 2020) and fulfilling inclusion criteria were screened for muco-cutaneous manifestations. Findings were recorded on a predesigned proforma. The data was statistically analysed and significant association between findings was recorded. Results: Total 50 (4.56%) children out of 1095 were positive for SARS-CoV-2 Reverse Transcription Polymerase Chain Reaction (RT-PCR) test and were admitted in Isolation Ward. Male to female ratio was 3:2 in present study. Four children had cutaneous manifestation: maculopapular rash (3/50) and urticarial lesions (1/50). All four patients had mild to moderate severity of disease. None of the patient had mucosal involvement. Conclusion: Appearance of dermatological findings among 8% of COVID-19 positive children warrants that all COVID-19 positive children should be screened for cutaneous findings.

Keywords

• coronavirus disease-2019
• maculopapular rash
• neonates
• urticarial lesions
• vasculopathic